Search

everythinglearnresearchcommunity

for

Search:↓

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Understanding how acne develops in different diseases could lead to new treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Both mouse and rat models are effective for testing alopecia areata treatments.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Probiotic bacteria improved skin and hair health in aged mice.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.